billHR8293Event Wednesday, April 15, 2026Analyzed

Abolish the CMMI Act

Neutral

Summary

HR8293 is an early-stage bill to abolish CMMI with no committee markups, no Senate companion, and no cosponsors. Market impact is negligible at this stage; no tickers meet the confidence threshold for inclusion.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR8293 is in the earliest legislative stage with zero momentum
  • 2.No cosponsors, no Senate companion, no hearings scheduled
  • 3.Market impact is negligible; no actionable investment thesis exists currently

Market Implications

No material market implications at this stage. If the bill were to advance, potential beneficiaries could include healthcare insurers favoring traditional Medicare fee-for-service ($UNH, $HUM, $CVS) and hospital systems ($HCA, $THC) that may face fewer value-based payment experiments. However, given the bill's current status, no actionable positions are warranted.

Full Analysis

HR8293, the 'Abolish the CMMI Act,' was introduced on April 15, 2026 by Rep. Bean (R-FL) and referred to the House Committees on Energy and Commerce and Ways and Means. The bill would abolish the Center for Medicare and Medicaid Innovation (CMMI) and repeal Section 1115A of the Social Security Act. The bill has no cosponsors, no companion legislation in the Senate, and has not received any committee markups or hearings. As a procedural early-stage bill, its legislative path is uncertain and likely requires significant additional momentum to advance. The bill does not authorize or appropriate any funding. Because CMMI's activities involve testing alternative payment models that can indirectly affect healthcare providers, insurers, and pharmaceutical pricing, any meaningful impact on publicly traded companies would require passage and implementation. At this early stage, the causal chain from bill introduction to specific company revenue impacts is too distant and speculative to meet confidence thresholds for ticker inclusion.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationJul 13, 2026

Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security

President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →